150 related articles for article (PubMed ID: 33720390)
21. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour.
Wolff H; Kunte C; Messer G; Rappersberger K; Held E; Löhrs U; Plewig G; Meurer M
Br J Dermatol; 1999 Feb; 140(2):313-6. PubMed ID: 10233229
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic pemphigus and Castleman's disease: a case report and a revision of the literature.
Irrera M; Bozzola E; Cardoni A; DeVito R; Diociaiuti A; El Hachem M; Girardi K; Marchesi A; Villani A
Ital J Pediatr; 2023 Mar; 49(1):33. PubMed ID: 36941723
[TBL] [Abstract][Full Text] [Related]
23. Clinical images: Castleman disease and paraneoplastic pemphigus.
Kop EN; MacKenzie MA
CMAJ; 2010 Jan; 182(1):61. PubMed ID: 19884299
[No Abstract] [Full Text] [Related]
24. Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor.
Jansen T; Plewig G; Anhalt GJ
Dermatology; 1995; 190(3):245-50. PubMed ID: 7599391
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy.
Hoque SR; Black MM; Cliff S
Clin Exp Dermatol; 2007 Mar; 32(2):172-5. PubMed ID: 17342796
[TBL] [Abstract][Full Text] [Related]
26. A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease.
Fang Y; Zhao L; Yan F; Cui X; Xia Y; Duren A
Med Oncol; 2010 Sep; 27(3):907-11. PubMed ID: 19763912
[TBL] [Abstract][Full Text] [Related]
27. Atypical pemphigus vulgaris associated with angio-follicular lymph node hyperplasia (Castleman's disease).
Coulson IH; Cook MG; Bruton J; Penfold C
Clin Exp Dermatol; 1986 Nov; 11(6):656-63. PubMed ID: 3665155
[No Abstract] [Full Text] [Related]
28. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.
Kikuchi T; Mori T; Shimizu T; Koda Y; Abe R; Kurihara Y; Funakoshi T; Yamagami J; Sato H; Tsunoda K; Amagai M; Okamoto S
Ann Hematol; 2017 Jul; 96(7):1221-1222. PubMed ID: 28447163
[No Abstract] [Full Text] [Related]
29. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor.
Lee IJ; Kim SC; Kim HS; Bang D; Yang WI; Jung WH; Chi HS
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):294-7. PubMed ID: 10025851
[TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic pemphigus in children and adolescents.
Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
[TBL] [Abstract][Full Text] [Related]
31. Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy.
Hwang YY; Chan JC; Trendell-Smith NJ; Kwong YL
Intern Med J; 2014 Nov; 44(11):1145-6. PubMed ID: 25367731
[No Abstract] [Full Text] [Related]
32. Fatal paraneoplastic pemphigus after removal of Castleman's disease in a child.
Daneshpazhooh M; Moeineddin F; Kiani A; Naraghi ZS; Firooz A; Akhyani M; Chams-Davatchi C
Pediatr Dermatol; 2012; 29(5):656-7. PubMed ID: 22276661
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic pemphigus and Castleman's disease in the setting of herpes simplex virus infection.
Koch LH; Layton CJ; Pilichowska M; Stadecker MJ; Barak O
Pediatr Dermatol; 2012; 29(5):629-32. PubMed ID: 22010956
[TBL] [Abstract][Full Text] [Related]
34. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour.
Kim SC; Chang SN; Lee IJ; Park SD; Jeong ET; Lee CW; Ahn CM; Anhalt GJ
Br J Dermatol; 1998 Apr; 138(4):667-71. PubMed ID: 9640377
[TBL] [Abstract][Full Text] [Related]
35. Follicular dendritic cell sarcoma aggravated by hyaline-vascular Castleman's disease in association with paraneoplastic pemphigus: study of the tumor and successful treatment.
Wang J; Wang X; Xu J; Song P
An Bras Dermatol; 2019; 94(5):578-581. PubMed ID: 31777359
[TBL] [Abstract][Full Text] [Related]
36. A Systematic Review of Patients with Mucocutaneous and Respiratory Complications in Paraneoplastic Autoimmune Multiorgan Syndrome: Castleman's Disease is the Predominant Malignancy.
Lee J; Bloom R; Amber KT
Lung; 2015 Aug; 193(4):593-6. PubMed ID: 25903794
[TBL] [Abstract][Full Text] [Related]
37. Anti-desmoglein antibody-negative paraneoplastic pemphigus successfully treated with rituximab.
Kanwar AJ; Vinay K; Varma S; Koga H; Ishii N; Hashimoto T
Int J Dermatol; 2015; 54(5):576-9. PubMed ID: 24738571
[No Abstract] [Full Text] [Related]
38. A case of paraneoplastic pemphigus associated with other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Sasaki H; Fujishima C; Hioki C; Yoshida H; Watanabe M; Murata T; Koga H; Ishii N; Kudo H
J Dermatol; 2022 May; 49(5):e165-e166. PubMed ID: 34989428
[No Abstract] [Full Text] [Related]
39. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
[TBL] [Abstract][Full Text] [Related]
40. Paraneoplastic pemphigus caused by pre-existing stroma-rich variant of Castleman disease: from a pathologist's point of view.
Gwiti P; Melegh Z; Johnston S; Sutak J
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
